Scott Kelley Email & Phone Number

Seek, develop and align residential construction contractors to advance the business objectives of said contractors thereby growing the product volume of James Hardie Building Products. This is accomplished by reviewing COGS models for inefficiencies, sales coaching to business owners, employing turn-key co-op marketing campaigns in targeted geographies and value proposition delivery. Act as a liaison between contractors, architects and homeowner associations to ensure that the James Hardie products are specified for residential construction projects. Efforts have resulted in multiple product conversions from competitor materials.

Cincinnati And Surrounding Area

Launched and promoted an innovative post-surgical analgesic to surgeons of multiple specialties in hospitals throughout the Dayton, Cincinnati and Northern Kentucky markets. Consulted and instructed surgeons and staff in the OR for proper preparation of the product and manage outcomes expectations to the OR and PACU staff for patients undergoing a wide variety of soft-tissue and orthopedic surgeries.• Achieved formulary status after one month of product availability at one of the region's largest hospital systems by delivering a strong value proposition to pharmacy and surgeons as well as P&T committee members• Achieved sales consistently in the top 20% of the national sales force• Earned "Exceeds Expectations" in annual review

Institutional Sales & OncologyRecruited to grow market share of Eisai products in Cincinnati and Northern Kentucky area hospitals. Worked with marketing and brand teams to gain market share and adapt strategies for resistant accounts, increasing annual territory revenue from $4MM to over $6MM for a single product . Managed individual promotional and expense budget of $30k annually. 2011 National rank: 15 / 112.• Achieved 241% to goal for fourth quarter 2011, top10% out of more than 250 in the United States, during launch of a new chemotherapy (Halaven) in December of 2010. Accomplished by leveraging relationships and differentiating over competing products.• Gained new responsibility of hypomethylating agent for MDS (Dacogen) July 1, 2009; 109% to goal for current quarter due to increased emphasis on hematologists.• Launched a new 5HT3 receptor antagonist (Aloxi) to anesthesiologists at outpatient surgery centers throughout greater Cincinnati, was first in the district to earn a sale (product promotion for this indication has since been discontinued by Eisai).• Grew a mature market product (Fragmin) and consistently improved sales rank for volume and market share by leveraging relationships with staff at each hospital such as hematology, orthopedics, ER, cardiology, hospitalists, pharmacy and purchasing. Consistently exceeded attainment goals for more than three years.

Promoted to manage both the Acute and Retail marketing of Lovenox and Plavix throughout a selected Cincinnati area. Produced a 188% increase in Plavix prescriptions in 2007 in the Acute arena due to strong relationships with interventional cardiologists, and a 67% increase in Retail by recommending extending the lengths of therapy; achieved an 18% increase in Lovenox in the retail arena, in 2007, against a company average of 12%.Made formal Lovenox presentations to clinical and corporate pharmacy leaders resulting in product growth and pathway placement.Defended a challenge to Lovenox formulary status at Deaconess Hospital resulting in sustained growth of the brand.Gained Operating Room experience by observing numerous angioplasties, heart valve replacements, CABG as well as knee and hip arthroplasty procedures to support product knowledge which has allowed me a fuller understanding of physician's concerns while in surgery and has increased my level of credibility with physicians and surgeons.Sales Representative 2002-2006Recruited to grow market share for three product lines: Lantus; Amaryl; and, from 2002 to 2003, Allegra. Called on primary care physicians in individual, small and large group practices. Achieved 100% Club every year, plus the 2004 National Sales Award for production (108.6%), and recognition for 105.9% in 2005. Internally recognized for producing a 23-point market share increase during the first full year in the territory - 2003.

Completed three major contract product promotions within the greater Cincinnati marketplace, targeting general practice physicians and pediatricians with the following results: Buspar: (Anxiety) - achieved 100% of personal production goals. Cefzil: (Antibiotic) - Top Producer on the Team. Monopril (Ace Inhibitor) - Team Lead and mentor; Top Sales Person in the district.

Bachelor Of Science, Marketing And Management

Mba Coursework

MBA in-process